OCI - instructions for use, doses, side effects, contraindications

auxiliary components: Glycerol 200 mg, ethanol 0.05 ml, methyl p-hydroxybenzoate 1.5 mg, flavoring mint 3 mg, menthol 0.7 mg, sodium saccharin 2 mg, Verde Chitose (brilliant green) 0.16 mg, sodium hydrophosphate 0.022 g, purified water 1 ml.

Description:

Transparent solution of green color with a characteristic smell of mint.

Pharmacotherapeutic group:Non-steroidal anti-inflammatory drug (NSAID)

ATX: & nbsp

M.02.A.A.10 Ketoprofen

Pharmacodynamics:

Has anti-inflammatory, analgesic and antipyretic effect. Inhibiting cyclooxygenase I and II type, inhibits the synthesis of prostaglandins. It has anti-bradykinin activity, stabilizes lysosomal membranes, and delays the release of enzymes that promote tissue destruction in chronic inflammation. Reduces the secretion of cytokines, inhibits the activity of neutrophils. The drug does not have antibacterial action.

Pharmacokinetics:After using 160 mg of ketoprofen lysine salt in the dosage form "topical solution", the plasma concentration of ketoprofen is low - less than 400 ng / ml and, therefore,It is insufficient for the expressed systemic pharmacological action.

Indications:

Symptomatic treatment of inflammatory diseases of ENT organs - angina, laryngitis, pharyngitis, tonsillitis; inflammatory diseases of the oral cavity - stomatitis, gingivitis, glossitis, aphtha, parodontopathy, chronic periodontitis; Used for dental manipulations as an analgesic.

Contraindications:Hypersensitivity (including to other NSAIDs), "aspirin" asthma.

Carefully:

Stomach ulcer and duodenal ulcer (exacerbation), ulcerative colitis (exacerbation), Crohn's disease, diverticulitis, peptic ulcer, hemophilia and other disorders of blood coagulation, CRF, children's age (up to 6 years), pregnancy (III trimester), lactation period.

Pregnancy and lactation:

Like other NSAIDs, Oki should not be used in the third trimester of pregnancy.

The use of the drug in I and II trimester should be carefully monitored by the attending physician.

Breastfeeding with the use of the drug should be discontinued.

Dosing and Administration:

Two rinses per day for 10 ml of OCI solution per dose.A solution of 10 ml should be measured with a measuring cup included in the package, and diluted in 100 ml (half a glass) of drinking water.

Accidental ingestion of the rinse solution does not lead to serious consequences. a single dose for rinsing contains 160 mg of ketoprofen lysine salt, which corresponds to a dose intended for oral administration.

Adolescents older than 12 years should use no more than 6 ml of OCI solution for half a cup of water.

Side effects:

Allergic reactions. If the product is swallowed, systemic side effects may develop.

Overdose:

At present, cases of Oka overdose have not been reported.

Interaction:Not found.

Special instructions:

Long-term use of external medicinal products may lead to sensitization. In this case, the drug should be discontinued and appropriate treatment methods should be selected.

Instructions for preparing a solution

Bring the sprayer into a functional position by turning the "spout" towards the inscription "open", to inject into the attached plastic cup by pressing the spray gun until it stops (the injection is repeated until the dose prescribed by the doctor is reached),dissolve the injected dose in 100 ml of drinking water (half a plastic cup).

Form release / dosage:

Solution for topical application 16 mg / ml.

Packaging:

For 150 ml of the drug in a plastic sealed bottle. The bottle is closed with a plastic lid, protected from opening by children.

1 bottle in a cardboard box with a plastic measuring cup for 10 ml and instructions for use.

Storage conditions:

At a temperature of no higher than 25 ° C.

Keep out of the reach of children!

Shelf life:

2 years.

Do not use the product after the date shown on the package.

Terms of leave from pharmacies:Without recipe

Registration number:П N010598 / 03

Date of registration:09.06.2010 / 25.01.2016

Expiration Date:Unlimited

The owner of the registration certificate:Dompe SpADompe SpA Italy

Manufacturer: & nbsp

DOMPE FARMACEUTICI, S.p.A. Italy

Representation: & nbspCBS CJSC LTDCBS CJSC LTDItaly

Information update date: & nbsp22.05.2017

Illustrated instructions

Instructions

OCI (OKI)